Fingerprint
Dive into the research topics of 'NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
Robert M.J. Deacon, Larry Glass, Mike Snape, Michael J. Hurley, Francisco J. Altimiras, Rodolfo R. Biekofsky, Patricia Cogram
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations